These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 165609)

  • 1. An experimental inactivated vaccine against bluetongue.
    Parker J; Herniman KA; Gibbs EP; Sellers RF
    Vet Rec; 1975 Mar; 96(13):284-7. PubMed ID: 165609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant virus vaccine for bluetongue disease in sheep.
    Roy P; Urakawa T; Van Dijk AA; Erasmus BJ
    J Virol; 1990 May; 64(5):1998-2003. PubMed ID: 2157868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation of a living attenuated vaccine against bluetongue type 20 virus.
    Wark MC; Shepherd-Clark MB; Smith HV; Collins WD
    Aust Vet J; 1982 Jul; 59(1):6-10. PubMed ID: 6293439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines.
    Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD
    Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of recombinant DNA technology for the development of a bluetongue virus subunit vaccine.
    Huismans H
    Onderstepoort J Vet Res; 1985 Sep; 52(3):149-51. PubMed ID: 3003649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and serological response of sheep to serial challenge with different bluetongue virus types.
    Jeggo MH; Gumm ID; Taylor WP
    Res Vet Sci; 1983 Mar; 34(2):205-11. PubMed ID: 6304836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency and efficacy of inactivated bluetongue virus vaccines.
    Stevens DR; Stott J; Osburn BI; Giles R; Wiesehahn GP; Barber TL
    Prog Clin Biol Res; 1985; 178():649-52. PubMed ID: 2989914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of research on an experimental inactivated bluetongue virus vaccine.
    Stott JL; Osburn BI; Barber TL
    Proc Annu Meet U S Anim Health Assoc; 1979; (83):55-62. PubMed ID: 233389
    [No Abstract]   [Full Text] [Related]  

  • 9. Bluetongue vaccine: cells and/or antibodies.
    Jeggo MH; Wardley RC
    Vaccine; 1985 Mar; 3(1):57-8. PubMed ID: 2988227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species.
    McConnell S; Morrill JC; Livingston CW
    Prog Clin Biol Res; 1985; 178():631-8. PubMed ID: 2989912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-propiolactone inactivated bivalent bluetongue virus vaccine containing Montanide ISA-71VG adjuvant induces long-term immune response in sheep against serotypes 4 and 16 even after 3 years of controlled vaccine storage.
    Zhugunissov K; Bulatov Y; Taranov D; Yershebulov Z; Koshemetov Z; Zhunushov A; Renukaradhya GJ; Tabynov K; Abduraimov Y
    Vet Microbiol; 2018 Nov; 226():23-30. PubMed ID: 30389040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines against bluetongue in Europe.
    Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of African horse-sickness virus by betapropiolactone and by pH.
    Parker J
    Arch Virol; 1975; 47(4):357-65. PubMed ID: 237497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of different vaccination schemes used in sheep combining inactivated bluetongue vaccines against serotypes 4 and 8.
    Hilke J; Strobel H; Woelke S; Stoeter M; Voigt K; Grimm L; Meilwes J; Punsmann T; Blaha I; Salditt A; Rohn K; Bastian M; Ganter M
    Vaccine; 2019 Sep; 37(39):5844-5853. PubMed ID: 31431410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep.
    Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M
    Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inactivated vaccine for the control of bluetongue virus serotype 16 infection in sheep in Italy.
    Savini G; Ronchi GF; Leone A; Ciarelli A; Migliaccio P; Franchi P; Mercante MT; Pini A
    Vet Microbiol; 2007 Sep; 124(1-2):140-6. PubMed ID: 17499459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and serological outcome following the simultaneous inoculation of three bluetongue virus types into sheep.
    Jeggo MH; Wardley RC; Taylor WP
    Res Vet Sci; 1984 Nov; 37(3):368-70. PubMed ID: 6097969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bluetongue Disabled Infectious Single Animal (DISA) vaccine: Studies on the optimal route and dose in sheep.
    van Rijn PA; Daus FJ; Maris-Veldhuis MA; Feenstra F; van Gennip RGP
    Vaccine; 2017 Jan; 35(2):231-237. PubMed ID: 27916409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the humoral response between sheep vaccinated with a killed-virus vaccine and those vaccinated with a modified-live virus vaccine against bluetongue virus serotype 17.
    Speiser KL; Schumaker BA; Cook WE; Cornish TE; Cammack KM; Miller MM
    J Am Vet Med Assoc; 2016 May; 248(9):1043-9. PubMed ID: 27074613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong protection induced by an experimental DIVA subunit vaccine against bluetongue virus serotype 8 in cattle.
    Anderson J; Hägglund S; Bréard E; Riou M; Zohari S; Comtet L; Olofson AS; Gélineau R; Martin G; Elvander M; Blomqvist G; Zientara S; Valarcher JF
    Vaccine; 2014 Nov; 32(49):6614-21. PubMed ID: 25312275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.